Lyell Immunopharma reported total assets of $311.15M and total liabilities of $77.34M for the quarter ended Jun 2026, down 19.3% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 393.50M | 293.83M | 222.60M | 205.74M | 116.31M | 123.55M | 109.43M | 224.37M | 286.21M | 145.65M | 125.65M | 133.42M | 100.30M | 105.60M | 120.33M | 98.80M | 123.58M | 60.18M | 90.77M | 72.98M | |||||
| Prepaid Assets | 12.23M | 11.49M | 11.79M | 11.21M | 11.61M | 11.14M | 11.63M | 10.66M | 11.42M | 8.46M | 7.87M | 8.71M | 9.50M | 9.07M | 8.00M | 5.42M | 8.58M | 13.72M | 13.28M | 9.44M | |||||
| Current Assets | 631.15M | 626.29M | 625.71M | 666.78M | 659.75M | 651.29M | 624.40M | 606.41M | 586.85M | 554.69M | 534.16M | 499.82M | 450.05M | 379.59M | 309.18M | 282.21M | 328.20M | 260.94M | 267.30M | 213.54M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 115.86M | 120.10M | 125.71M | 127.56M | 125.73M | 123.02M | 118.60M | 113.68M | 108.10M | 102.65M | 97.84M | 93.10M | 88.05M | 48.20M | 44.20M | 39.12M | 36.72M | 34.77M | 32.72M | 30.51M | |||||
| Long-Term Investments | 317.51M | 283.53M | 224.12M | 131.44M | 102.52M | 70.12M | 55.26M | 36.95M | 32.00M | 32.00M | 19.00M | 19.00M | 20.11M | 19.00M | 28.95M | 20.06M | 19.00M | 19.00M | 19.00M | 23.90M | |||||
| Other Non-Current Assets | 0.47M | 0.47M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.29M | 0.29M | 0.29M | 4.62M | 1.69M | 1.58M | 2.54M | 4.89M | 5.23M | 5.84M | |||||
| Non-Current Assets | 567.19M | 501.12M | 446.40M | 354.90M | 317.52M | 286.27M | 256.05M | 228.94M | 208.13M | 195.34M | 160.06M | 154.32M | 169.17M | 111.27M | 120.62M | 103.24M | 79.76M | 79.11M | 83.32M | 97.61M | |||||
| Assets | 1,198.33M | 1,127.41M | 1,072.10M | 1,021.67M | 977.27M | 937.56M | 880.45M | 835.35M | 794.99M | 750.03M | 694.22M | 654.14M | 619.22M | 490.86M | 429.80M | 385.45M | 407.96M | 340.05M | 350.63M | 311.15M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 3.53M | 3.21M | 6.51M | 4.25M | 4.79M | 3.92M | 5.73M | 5.80M | 4.37M | 4.82M | 4.89M | 4.20M | 3.60M | 5.37M | 3.73M | 3.38M | 2.57M | 2.89M | 5.47M | 3.88M | |||||
| Payables | 3.53M | 3.21M | 6.51M | 4.25M | 4.79M | 3.92M | 5.73M | 5.80M | 4.37M | 4.82M | 4.89M | 4.20M | 3.60M | 5.37M | 3.73M | 3.38M | 2.57M | 2.89M | 5.47M | 3.88M | |||||
| Accumulated Expenses | 25.06M | 29.06M | 22.69M | 21.40M | 23.57M | 28.75M | 22.42M | 24.83M | 29.65M | 28.13M | 24.91M | 25.67M | 29.01M | 40.82M | 31.17M | 28.00M | 29.31M | 46.52M | 31.48M | 35.99M | |||||
| Current Deferred Revenue | 5.58M | 4.99M | 6.22M | 15.43M | 11.19M | ||||||||||||||||||||
| Total Current Liabilities | 59.28M | 46.74M | 41.05M | 50.29M | 51.22M | 37.03M | 30.80M | 34.39M | 35.06M | 34.52M | 32.35M | 30.88M | 33.51M | 53.79M | 41.28M | 36.90M | 31.88M | 49.41M | 36.95M | 39.87M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Non-Current Deffered Revenue | 81.88M | 79.67M | 77.87M | 32.93M | 37.16M | ||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||
| Operating Leases | 65.68M | 66.65M | 68.81M | 67.55M | 67.47M | 63.17M | 66.64M | 66.07M | 64.64M | 56.89M | 61.83M | 60.22M | 58.58M | 50.99M | 57.09M | 55.11M | 53.07M | 41.92M | 48.85M | 46.60M | |||||
| Other Non-Current Liabilities | 5.01M | 4.57M | 4.45M | 4.34M | 4.23M | 4.11M | 4.00M | 3.89M | 3.78M | 3.66M | 3.55M | 3.44M | 3.56M | 7.60M | 6.39M | 5.53M | 2.68M | 0.52M | 0.53M | 0.54M | |||||
| Total Non-Current Liabilities | 206.85M | 193.05M | 186.40M | 149.29M | 153.02M | 100.20M | 92.62M | 94.61M | 93.64M | 91.41M | 87.51M | 84.20M | 84.95M | 100.44M | 86.89M | 81.00M | 76.16M | 91.33M | 76.43M | 76.80M | |||||
| Total Liabilities | 211.86M | 197.62M | 190.85M | 153.63M | 157.24M | 104.31M | 96.62M | 98.50M | 97.42M | 95.08M | 91.06M | 87.64M | 88.52M | 108.03M | 93.28M | 86.53M | 78.84M | 91.85M | 76.96M | 77.34M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Common Equity | 986.47M | 929.79M | 881.25M | 868.04M | 820.03M | 833.25M | 783.83M | 736.86M | 697.57M | 654.95M | 603.16M | 566.50M | 530.70M | 382.82M | 336.52M | 298.92M | 329.12M | 248.20M | 273.67M | 233.81M | |||||
| Liabilities and Shareholders Equity | 1,198.33M | 1,127.41M | 1,072.10M | 1,021.67M | 977.27M | 937.56M | 880.45M | 835.35M | 794.99M | 750.03M | 694.22M | 654.14M | 619.22M | 490.86M | 429.80M | 385.45M | 407.96M | 340.05M | 350.63M | 311.15M | |||||
| Retained Earnings | -500.66M | 1,515.75M | 1,540.33M | 1,565.20M | 1,589.08M | 1,608.31M | 1,622.12M | 1,637.54M | 1,647.91M | 1,657.13M | 1,666.32M | 1,675.46M | 1,683.08M | 1,727.64M | 1,733.63M | 1,738.85M | 1,807.75M | 1,867.51M | 1,917.38M | 1,922.43M | |||||
| Preferred Shares | 10.00M | ||||||||||||||||||||||||
| Treasury Shares |